Patents by Inventor Jo-Hsin Tang

Jo-Hsin Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHALABLE LIPOSOMAL SUSTAINED RELEASE COMPOSITION FOR USE IN TREATING PULMONARY DISEASES
    Publication number: 20230088661
    Abstract: Provided is a liposomal sustained-release composition for use in treatment of pulmonary disease. The liposomal sustained release composition comprises a liposome that includes a polyethylene glycol (PEG)-modified lipid and encapsulates a tyrosine kinase inhibitor. Tyrosine kinase inhibitor is stably entrapped in the liposome, and the resulting liposomal drug formulation can be aerosolized or nebulized for administration via inhalation. This aerosolized liposomal drug formulation yields consistent pharmacokinetic and pharmacodynamic profiles while achieving desired efficacy and safety.
    Type: Application
    Filed: November 22, 2022
    Publication date: March 23, 2023
    Inventors: Keelung Hong, Jonathan Fang, Yu-Cheng Tseng, Ting-Yu Cheng, Wan-Ni Yu, Jo-Hsin Tang
  • Inhalable liposomal sustained release composition for use in treating pulmonary diseases
    Patent number: 11534399
    Abstract: Provided is a liposomal sustained-release composition for use in treatment of pulmonary disease. The liposomal sustained release composition comprises a liposome that includes a polyethylene glycol (PEG)-modified lipid and encapsulates a tyrosine kinase inhibitor. Tyrosine kinase inhibitor is stably entrapped in the liposome, and the resulting liposomal drug formulation can be aerosolized or nebulized for administration via inhalation. This aerosolized liposomal drug formulation yields consistent pharmacokinetic and pharmacodynamic profiles while achieving desired efficacy and safety.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: December 27, 2022
    Assignee: INSPIRMED CORP.
    Inventors: Keelung Hong, Jonathan Fang, Yu-Cheng Tseng, Ting-Yu Cheng, Wan-Ni Yu, Jo-Hsin Tang
  • INHALABLE SUSTAINED RELEASE COMPOSITION OF BRONCHODILATOR FOR USE IN TREATING PULMONARY DISEASE
    Publication number: 20220211623
    Abstract: Provided is a liposomal sustained release composition of bronchodilator for use in treatment of pulmonary disease. The liposomal bronchodilator has a liposome containing a bronchodilator entrapped in the liposome. The bronchodilator has been stably encapsulated in the liposome, and the resulting liposomal bronchodilator is proven to be stably aerosolized or nebulized for administration via the inhalation route to treat a subject in need thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: July 7, 2022
    Inventors: Keelung HONG, Jonathan FANG, Yun-Long TSENG, Wan-Ni YU, Ting-Yu CHENG, Jo-Hsin TANG
  • INHALABLE LIPOSOMAL SUSTAINED RELEASE COMPOSITION FOR USE IN TREATING PULMONARY DISEASES
    Publication number: 20210145740
    Abstract: Provided is a liposomal sustained-release composition for use in treatment of pulmonary disease. The liposomal sustained release composition comprises a liposome that includes a polyethylene glycol (PEG)-modified lipid and encapsulates a tyrosine kinase inhibitor. Tyrosine kinase inhibitor is stably entrapped in the liposome, and the resulting liposomal drug formulation can be aerosolized or nebulized for administration via inhalation. This aerosolized liposomal drug formulation yields consistent pharmacokinetic and pharmacodynamic profiles while achieving desired efficacy and safety.
    Type: Application
    Filed: April 23, 2019
    Publication date: May 20, 2021
    Inventors: Keelung Hong, Jonathan Fang, Yu-Cheng Tseng, Ting-Yu Cheng, Wan-Ni Yu, Jo-Hsin Tang